232 related articles for article (PubMed ID: 12843223)
1. 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma.
Rini JN; Leonidas JC; Tomas MB; Palestro CJ
J Nucl Med; 2003 Jul; 44(7):1072-4. PubMed ID: 12843223
[TBL] [Abstract][Full Text] [Related]
2. Use of 18F-FDG PET/CT imaging for evaluation of patients with primary splenic lymphoma.
Karunanithi S; Sharma P; Roy SG; Vettiyil B; Sharma A; Thulkar S; Bal C; Kumar R
Clin Nucl Med; 2014 Sep; 39(9):772-6. PubMed ID: 25036015
[TBL] [Abstract][Full Text] [Related]
3. CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma.
de Jong PA; van Ufford HM; Baarslag HJ; de Haas MJ; Wittebol SH; Quekel LG; de Klerk JM
AJR Am J Roentgenol; 2009 Mar; 192(3):745-53. PubMed ID: 19234273
[TBL] [Abstract][Full Text] [Related]
4. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
Liu Y
Nucl Med Commun; 2017 Apr; 38(4):319-324. PubMed ID: 28225435
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT in splenic marginal zone lymphoma.
Albano D; Giubbini R; Bertagna F
Abdom Radiol (NY); 2018 Oct; 43(10):2721-2727. PubMed ID: 29500652
[TBL] [Abstract][Full Text] [Related]
6. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
Gayed I; Vu T; Iyer R; Johnson M; Macapinlac H; Swanston N; Podoloff D
J Nucl Med; 2004 Jan; 45(1):17-21. PubMed ID: 14734662
[TBL] [Abstract][Full Text] [Related]
7. Solid splenic masses: evaluation with 18F-FDG PET/CT.
Metser U; Miller E; Kessler A; Lerman H; Lievshitz G; Oren R; Even-Sapir E
J Nucl Med; 2005 Jan; 46(1):52-9. PubMed ID: 15632034
[TBL] [Abstract][Full Text] [Related]
8. Solitary splenic lymphoma detected with (18)F-FDG-PET/CT.
Tamam M; Mulazimoglu M; Yavuz H; Aydin T; Filiz F; Ozpacaci T
Hell J Nucl Med; 2011; 14(2):179-80. PubMed ID: 21761026
[No Abstract] [Full Text] [Related]
9. Accuracy of whole-body MRI in the assessment of splenic involvement in lymphoma.
Littooij AS; Kwee TC; Barber I; Granata C; de Keizer B; Beek FJ; Hobbelink MG; Fijnheer R; Stoker J; Nievelstein RA
Acta Radiol; 2016 Feb; 57(2):142-51. PubMed ID: 25681490
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
Qiao WL; Zhao JH; Wang C; He ZY; Wang TS; Xing Y
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):536-9. PubMed ID: 18069637
[TBL] [Abstract][Full Text] [Related]
11. F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease.
Rini JN; Manalili EY; Hoffman MA; Karayalcin G; Mehrotra B; Tomas MB; Palestro CJ
Clin Nucl Med; 2002 Aug; 27(8):572-7. PubMed ID: 12170002
[TBL] [Abstract][Full Text] [Related]
12. Low rate of spleen involvement in sporadic Burkitt lymphoma at staging on PET-CT.
Davidson T; Priel E; Schiby G; Raskin S; Chikman B; Nissan E; Benjamini O; Nissan J; Goshen E; Ben-Haim S; Salomon O; Avigdor A
Abdom Radiol (NY); 2018 Sep; 43(9):2369-2374. PubMed ID: 29460043
[TBL] [Abstract][Full Text] [Related]
13. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M
Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362
[TBL] [Abstract][Full Text] [Related]
14. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN
Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.
Asenbaum U; Nolz R; Karanikas G; Furtner J; Woitek R; Staudenherz A; Senn D; Raderer M; Weber M; Simonitsch-Klupp I; Mayerhoefer ME
PLoS One; 2016; 11(10):e0164118. PubMed ID: 27723817
[TBL] [Abstract][Full Text] [Related]
16. Utility of 18F-FDG PET/CT for staging NK/T-cell lymphomas.
Wu HB; Wang QS; Wang MF; Li HS; Zhou WL; Ye XH; Wang QY
Nucl Med Commun; 2010 Mar; 31(3):195-200. PubMed ID: 20009963
[TBL] [Abstract][Full Text] [Related]
17. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.
Kato T; Tsukamoto E; Kuge Y; Katoh C; Nambu T; Nobuta A; Kondo S; Asaka M; Tamaki N
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1047-54. PubMed ID: 12173019
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.
Kumar R; Xiu Y; Potenta S; Mavi A; Zhuang H; Yu JQ; Dhurairaj T; Dadparvar S; Alavi A
J Nucl Med; 2004 Nov; 45(11):1796-803. PubMed ID: 15534046
[TBL] [Abstract][Full Text] [Related]
19. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
Moon SH; Cho SK; Kim WS; Kim SJ; Chan Ahn Y; Choe YS; Lee KH; Kim BT; Choi JY
J Nucl Med; 2013 Jul; 54(7):1039-44. PubMed ID: 23658217
[TBL] [Abstract][Full Text] [Related]
20. Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience.
Tatsumi M; Cohade C; Nakamoto Y; Fishman EK; Wahl RL
Radiology; 2005 Dec; 237(3):1038-45. PubMed ID: 16304117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]